A clinical application study of metabolomics/miRNA in the treatment of IV stage Diabetic kidney disease patients with nourishing Yang and removing stasis method
- Conditions
- Diabetic kidney disease
- Registration Number
- ITMCTR2024000158
- Lead Sponsor
- Yirui Zhao
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- Not specified
(1) A definite history of diabetes;
(2) Ages between 40 and 75 years old, gender not specified;
(3) Blood pressure controlled within the range of 90-130mmHg/70-90mmHg;
(4) Meet the diagnostic criteria for type 2 diabetes in phase IV of the Chinese Medical Association Diabetes Branch's Guidelines for the Prevention and Treatment of Diabetes in China (2020);
(5) Inclusion of patients who meet the criteria for yang deficiency and blood stasis according to traditional Chinese medicine;
(6) Understand the entire process of the trial and voluntarily participate and sign the informed consent form.
(1) Patients in stages I, II, III, and V of DKD;
(2) Patients diagnosed with type 1 diabetes or other types of diabetes;
(3) Primary renal diseases and other secondary renal diseases not caused by diabetes;
(4) Patients with diabetic ketoacidosis and urinary tract infections within the past month;
(5) Patients with other serious organic diseases (such as cardiovascular diseases, severe hematological diseases, tumors, etc.);
(6) Women during pregnancy or lactation;
(7) Patients with mental illness or non-compliance with instructions;
(8) Patients with a history of allergies or sensitivity to other drugs;
(9) Other patients participating in clinical trials of other drugs.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method